Open AccessExtended spectrum beta-lactamase detection in gram-negative bacilli of nosocomial origin
Author(s) -
Ranabir Pal,
DechenC Tsering,
Shyamasree Das,
Luna Adhiakari,
TakhellambamS.K Singh
Publication year - 2009
Publication title -
journal of global infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.437
H-Index - 25
eISSN - 0974-8245
pISSN - 0974-777X
DOI - 10.4103/0974-777x.56247
Subject(s) - microbiology and biotechnology , morganella morganii , piperacillin , enterobacter cloacae , ampicillin , cefotaxime , cephalosporin , klebsiella pneumoniae , beta lactamase , proteus mirabilis , pseudomonas aeruginosa , citrobacter freundii , medicine , antibiotics , tazobactam , antibiotic resistance , gentamicin , biology , imipenem , escherichia coli , bacteria , gene , genetics , biochemistry
Resistance to third generation cephalosporins by acquisition and expression of extended spectrum beta lactamase (ESBL) enzymes among gram-negative bacilli is on a rise. The presence of ESBL producing organisms significantly affects the course and outcome of an infection and poses a challenge to infection management worldwide.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom